17th Closed Scientific Expert Meeting of the Editorial Board
siRNA-mediated lowering of Lp(a) by Olpasiran
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Michael Koren
read more »A new ASO PCSK9 inhibitor: The Etesian study
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Alexis Hofherr
read more »ASO-mediated reduction in Lp(a) levels: Update on Pelacarsen
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Sotirios Tsimikas
read more »siRNA-mediated lowering of Lp(a) by SLN360
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Steve Nissen
read more »PCSK9 and diabetes risk
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Wilfried Le Goff
read more »Keynote: Clinical utility of cIMT in determining management of children with heFH and of CTCA in determining treatment effects in children with hoFH
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Albert Wiegman
read more »How much reduction of Lp(a) is needed to translate into major clinical benefit? Setting the scene: Focus on PCSK9 inhibitors
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Pia Kamstrup
read more »